The Drug Coated Balloon-Only Strategy for Treatment of de Novo Left Main Coronary Artery Bifurcation Lesion: Stentless Strategy

The Drug Coated Balloon-Only Strategy for Treatment of de Novo Left Main Coronary Artery Bifurcation Lesion: Stentless Strategy

Blog Article

The study aimed to evaluate the efficacy and safety of drug coated balloon-only strategy (DCB-only) in the treatment of de novo left Aprons main coronary artery (LM) bifurcation lesions.85 patients were enrolled in this study and classified them into two groups: DCB-only group (n = 36) and DES group (n = 49).The MLD of target vessels was measured before and immediately after percutaneous coronary intervention (PCI) and late luminal loss (LLL) were also calculated.And the occurrence 3 Piece Full Bookcase Bed of major adverse cardiovascular events (MACE) was also evaluated.Compared with that before PCI, the MLD of target lesions significantly increased immediately after PCI ( P.

05).The use of DCB-only to treat de novo LM bifurcation lesions is effective and relatively safe, which provides new ideas for the treatment of LM coronary artery bifurcation lesions in the future.